Nexia Biotechnologies of Montreal, Quebec, Canada, has signed an agreement with Defence R & D Canada-Suffield (DRDC) of Alberta to research and test Protexia (formerly NEX-91), a protein designed to protect people against the toxic effects of nerve agents and other organophosphate agents....